Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
EditorialEditorial
Open Access

Antimicrobial resistance

Insights from the declaration of World Alliance Against Antibiotic Resistance

Mushira A. Enani
Saudi Medical Journal January 2015, 36 (1) 11-12; DOI: https://doi.org/10.15537/smj.2015.1.10362
Mushira A. Enani
From the Infectious Diseases Section, Department of Medicine, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
FRCPE, FACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected] [email protected]
  • Article
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Antimicrobial resistance (AR) is a growing public health threat of broad concern to countries and multiple sectors.1 According to Nathan and Cars,2 Alexander Fleming and Howard Florey sounded the first warning regarding AR during their 1945 Nobel Prize for the discovery of penicillin. Serious infections caused by multi-drug and pan-drug resistant bacteria in the face of dry pipeline of new antibiotics make practicing modern medicine of enormous challenge. It is estimated that at a minimum of 25000 patients in Europe, and 23000 in the USA die each year from infections caused by antibiotic-resistant bacteria.3 Development and dissemination of AR is directly related to the amount and the pattern of antibiotics we prescribe in our daily practice. A national surveillance of AR among gram-positive bacteria in the Kingdom of Saudi Arabia (KSA) revealed high resistance among Staphylococcus aureus (methicillin-resistant S. aureus: 32%), coagulase-negative staphylococci (oxacillin: 63%), and pneumococci (penicillin G - 33%; erythromycin - 26%; ceftriaxone - 11%).4 The Gulf Cooperation Council (GCC) States share a high prevalence of extended-spectrum-β-lactamase (ESBL) and carbapenemase-producing gram negative bacilli, most of which are associated with nosocomial infections.5 In the latter study, the rate of ESBL Escherichia coli (E. coli) and Klebsiella in different regions of KSA ranged from 4.8-29% for E. coli, and 3.2-64% for Klebsiella, while the rate was 14% for carbapenem-resistant Enterobacteriaceae, and 5-20% for Pseudomonas.

The World Alliance Against Antibiotic Resistance (WAAAR) is a nonprofit organization open to professionals and consumers worldwide. It constitutes a group of 700 individuals from 55 different countries representing all the key stakeholders (physicians, veterinarians, microbiologists, surgeons, pharmacists, nurses, evolutionary biologists, ecologists, environmentalists, and patient advocacy groups).3,6 The Alliance receives support from more than 140 scientific societies or professional groups throughout the world. Among the supporters is the Saudi Society of Medical Microbiology and Infectious Diseases.

The WAAR declaration was published in June 2014 to actively promote preservation of existing antibiotics, and raise awareness among prescribers, politicians, and policy-makers, patient safety and advocacy groups, pharmaceutical industry, international organizations and general population.6 The declaration advocates 10 actions to combat antibiotic resistance: 1) spreading awareness of all the stakeholders and the general public to AR threat; 2) establishing a national plan by the Ministers of Health, or regulatory bodies in each country for the containment of AR; 3) continuous access to antibiotics of established quality, especially in middle and low income countries; 4) integrated surveillance of AR and antibiotic consumption; 5) use of diagnostic tests; 6)antimicrobial stewardship; 7) educational efforts for cultural change; 8) infection prevention to contain bacterial spread; 9) basic and applied research and development of new antibiotics; and 10) request for UNESCO to include the “concept of antibiotic” in the list of the intangible cultural heritage. In 2014 September 18th, the United States President’s Council of Advisors on Science and Technology (PCAST) released a report to the President, Combating Antibiotic Resistance. The report was linked to an executive order from US President Barack Obama, who directed the National Security Council to work with a governmental task force and a non-governmental advisory council to develop a national action plan by February 2015.2

Detecting, preventing, and controlling antibiotic resistance requires strategic, coordinated, and sustained efforts. It also depends on the engagement of governments, academia, industry, healthcare providers, the general public, and the agricultural community, as well as international partners. Committing to combating antibiotic-resistant microbes will support patient care, economic growth, agriculture, and economic and national security.

Supplements

  • * Supplements will be considered for work including proceedings of conferences or subject matter covering an important topic.

  • * Material can be in the form of original work or abstracts.

  • * Material in supplements will be for the purpose of teaching rather than research.

  • * The Guest Editor will ensure that the financial cost of production of the supplement is covered.

  • * Supplements will be distributed with the regular issue of the journal but further copies can be ordered upon request.

  • * Material will be made available on Saudi Medical Journal website.

Footnotes

  • Disclosure. The author have no conflict of interests, and the work was not supported or funded by any drug company.

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. ↵
    (2014) World Health Organization. Antimicrobial resistance: global report on surveillance. Available from: http://www.who.int/drugresistance/documents/surveillancereport/en.
  2. ↵
    1. Nathan C,
    2. Cars O
    (2014) Antibiotic resistance--problems, progress, and prospects. New Engl J Med 371:1761–1763.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Carlet J
    (2014) Antibiotic resistance: Protecting antibiotics - the declaration of the world alliance against antibiotic resistance. Indian J Crit Care Med 18:643–645.
    OpenUrl
  4. ↵
    1. Shibl AM,
    2. Memish ZA,
    3. Kambal AM,
    4. Ohaly YA,
    5. Ishaq A,
    6. Senok AC,
    7. et al.
    (2014) National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia. J Chemother 26:13–18.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Zowawi HM,
    2. Balkhy HH,
    3. Walsh TR,
    4. Paterson DL
    (2013) β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clin Microbiol Rev 26:361–380.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Carlet J,
    2. WAAA
    World Alliance Against Antibiotic Resistance. The WAAAR declaration against antibiotic resistance. Available from: http://www.ac2bmr.fr/images/DECLARATION_WAAAR_VA.pdf.
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (1)
Saudi Medical Journal
Vol. 36, Issue 1
1 Jan 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antimicrobial resistance
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Antimicrobial resistance
Mushira A. Enani
Saudi Medical Journal Jan 2015, 36 (1) 11-12; DOI: 10.15537/smj.2015.1.10362

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antimicrobial resistance
Mushira A. Enani
Saudi Medical Journal Jan 2015, 36 (1) 11-12; DOI: 10.15537/smj.2015.1.10362
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • References
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Artificial intelligence (AI) in medical publications pros and cons
  • Building a healthy future for all
  • Saudi Medical Journal Message
Show more Editorial

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire